DK1011704T3 - Tumornekrose-faktor-receptor-afledte peptid-analiger - Google Patents

Tumornekrose-faktor-receptor-afledte peptid-analiger

Info

Publication number
DK1011704T3
DK1011704T3 DK98923839T DK98923839T DK1011704T3 DK 1011704 T3 DK1011704 T3 DK 1011704T3 DK 98923839 T DK98923839 T DK 98923839T DK 98923839 T DK98923839 T DK 98923839T DK 1011704 T3 DK1011704 T3 DK 1011704T3
Authority
DK
Denmark
Prior art keywords
necrosis factor
tumor necrosis
factor receptor
tnf
derived peptide
Prior art date
Application number
DK98923839T
Other languages
English (en)
Inventor
Ramachandran Murali
Mark I Greene
Wataru Takasaki
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Application granted granted Critical
Publication of DK1011704T3 publication Critical patent/DK1011704T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98923839T 1997-05-30 1998-05-29 Tumornekrose-faktor-receptor-afledte peptid-analiger DK1011704T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/866,545 US6265535B1 (en) 1997-05-30 1997-05-30 Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses
PCT/US1998/010891 WO1998053842A1 (en) 1997-05-30 1998-05-29 Tumor necrosis factor receptor-derived peptide analogues

Publications (1)

Publication Number Publication Date
DK1011704T3 true DK1011704T3 (da) 2007-04-23

Family

ID=25347839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923839T DK1011704T3 (da) 1997-05-30 1998-05-29 Tumornekrose-faktor-receptor-afledte peptid-analiger

Country Status (10)

Country Link
US (1) US6265535B1 (da)
EP (2) EP1837344A1 (da)
AT (1) ATE348106T1 (da)
AU (4) AU744925B2 (da)
CA (1) CA2291963C (da)
DE (1) DE69836638T2 (da)
DK (1) DK1011704T3 (da)
ES (1) ES2279575T3 (da)
PT (1) PT1011704E (da)
WO (1) WO1998053842A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000021981A2 (de) * 1998-10-09 2000-04-20 Bioserv Ag TNFα BINDENDE PEPTIDE UND IHRE ANWENDUNG FÜR DIE DETEKTION, INAKTIVIERUNG UND/ODER ENTFERNUNG VON TNFα AUS BIOLOGISCHEN FLÜSSIGKEITEN
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
HK1042114B (zh) 1998-10-23 2006-09-29 Amgen K-A, Inc. 与mp1受体结合并具有血小板生成活性的模拟二聚体血小板生成素肽
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
IL130989A0 (en) 1999-07-20 2001-01-28 Compugen Ltd Variants of alternative splicing
US6673771B1 (en) 1999-07-28 2004-01-06 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclast activity
AU777634B2 (en) * 1999-07-28 2004-10-28 Kazuhiro Aoki Methods of inhibiting osteoclastogenesis
US6682739B1 (en) * 1999-07-28 2004-01-27 The Trustees Of The University Of Pennsylvania Methods of inhibiting osteoclastogenesis
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
AU2001279313B2 (en) 2000-08-04 2007-03-01 Ampio Pharmaceuticals, Inc. Method of using diketopiperazines and composition containing them
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
DE60334452D1 (de) 2002-05-23 2010-11-18 Univ Pennsylvania Fas peptid-mimetika und ihre verwendungszwecke
CA2490409A1 (en) 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
ATE520981T1 (de) * 2002-10-02 2011-09-15 Dmi Biosciences Inc Diagnose und überwachung von krankheiten
CA3050734A1 (en) 2003-05-15 2004-12-02 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
US7304115B2 (en) * 2003-12-30 2007-12-04 3M Innovative Properties Company Fluoropolymer coagulation method and composition
CA2572765C (en) 2004-07-08 2013-05-21 Amgen Inc. Compound having improved bioefficiency when administered in a multidose regimen
US7442778B2 (en) 2004-09-24 2008-10-28 Amgen Inc. Modified Fc molecules
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9283260B2 (en) 2006-04-21 2016-03-15 Amgen Inc. Lyophilized therapeutic peptibody formulations
WO2009146320A1 (en) 2008-05-27 2009-12-03 Dmi Life Sciences, Inc. Therapeutic methods and compounds
CN102770458A (zh) * 2009-12-02 2012-11-07 阿塞勒隆制药公司 用于增加Fc融合蛋白的血清半寿期的组合物和方法
US8507496B2 (en) 2010-09-07 2013-08-13 Dmi Acquisition Corp. Treatment of diseases
EP2684888B1 (en) * 2011-03-09 2019-05-15 Jitsubo Co., Ltd. Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
EA027343B1 (ru) 2011-10-10 2017-07-31 Ампио Фармасьютикалз, Инк. Имплантируемые устройства медицинского назначения с повышенной иммунной толерантностью и способы изготовления и имплантирования
EP2766029B1 (en) 2011-10-10 2020-03-25 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease
CA2846394A1 (en) 2011-10-28 2013-05-02 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
AU2015305611B2 (en) 2014-08-18 2020-04-23 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
GB9402331D0 (en) * 1994-02-07 1994-03-30 Univ Mcgill Nerve growth factor structural analogs and their uses

Also Published As

Publication number Publication date
PT1011704E (pt) 2007-03-30
DE69836638D1 (de) 2007-01-25
EP1011704B1 (en) 2006-12-13
CA2291963C (en) 2011-04-19
ATE348106T1 (de) 2007-01-15
AU778124B2 (en) 2004-11-18
AU2005200634A1 (en) 2005-03-17
AU4584402A (en) 2002-07-25
EP1011704A1 (en) 2000-06-28
AU2008243270B2 (en) 2011-09-01
AU2008243270A1 (en) 2008-12-11
WO1998053842A1 (en) 1998-12-03
EP1837344A1 (en) 2007-09-26
AU744925B2 (en) 2002-03-07
DE69836638T2 (de) 2007-10-04
CA2291963A1 (en) 1998-12-03
EP1011704A4 (en) 2002-07-31
ES2279575T3 (es) 2007-08-16
US6265535B1 (en) 2001-07-24
AU7603698A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
EP1011704A4 (en) ANALOGS OF PEPTIDES DERIVED FROM TUMOR NECROSIS FACTOR RECEPTORS
DK1012274T3 (da) Dödsdomæneholdig receptor-4 (DR4: dödsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L)
ATE168415T1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
BR9812096A (pt) Proteìna receptora/ligante solúvel interleucina-6 quimérica, seus análogos e seus usos
DK2116259T3 (da) TACI-immunoglobulinfusionsproteiner
DK0964874T3 (da) CAML-bindende lymfocytoverfladereceptor, nukleinsyrer, som koder derfor, og fremgangsmåder til anvendelse deraf
EP1496935A4 (en) AGONISTS AND ANTAGONISTS OF INSULIN RECEPTOR AND IGF-1
PL348529A1 (en) Receptor based antagonists and methods of making and using
WO2002002627A3 (en) Interferon-like protein zcyto21
EP1589106A4 (en) ADIPONEKTIN RECEPTOR AND GENERATING ENCODER
DE60030450D1 (de) Von MUC-1 abgeleitete Peptide
WO1997024436A3 (en) Ligand polypeptides for the g-protein-coupled receptor protein, their production and use
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
DE60014575D1 (de) Stabilisierende Peptide, und Polypeptide und Antikörper die diese beinhalten
DK1607745T3 (da) Ligand til G-proteinkoplet receptor FPRL2 og anvendelser deraf
DE69417223D1 (de) Ein menschlicher t-zell rezeptor der protein g-gekoppelte rezeptor familie
DE602004019701D1 (de) Peptide welche an Apo2L (Trail) Rezeptoren binden und Verwendungen davon
UA72875C2 (uk) БІЛКИ, ЯКІ ЗВ'ЯЗУЮТЬСЯ З <font face="Symbol">b</font>-АМІЛОЇДНИМ ПЕПТИДОМ ТА ПОЛІНУКЛЕОТИДИ, ЩО ЇХ КОДУЮТЬ
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
DE69328060D1 (de) Angiotensin-II Typ-1 Rezeptor und dessen Herstellung
ATE442444T1 (de) Glykosylphosphatidylinositolhaltige polypeptide
Cody et al. Modifications of the C-Terminal Dipeptide of Angiotensin II Yielded a Novel Series of Analogues with Type II (AT~ 2) Receptor Selectivity
EA200400384A1 (ru) Растворимый рецептор т-клетки
WO1999027097A3 (en) CLONING OF A TETRODOTOXIN-RESISTANT SODIUM CHANNEL α-SUBUNIT
ATE163652T1 (de) Antikörper gegen das carboxy-terminale peptid des somatotropin-bindungsproteins der ratte